Aarti Drugs posts Q2 FY25 consolidated profit at Rs. 35.01 Cr
News

Aarti Drugs posts Q2 FY25 consolidated profit at Rs. 35.01 Cr

Aarti Drugs has reported total income of Rs. 599.81 crores during the period ended September 30, 2024

  • By IPP Bureau | October 26, 2024

Aarti Drugs Limited has reported consolidated financial results for the period ended September 30, 2024.

Aarti Drugs has posted net profit of Rs. 35.01 crores for the period ended September 30, 2024 as against net profit of Rs. 33.24 crores for the period ended June 30, 2024. The company posted net profit of Rs.39.59 crores for the period ended September 30, 2023.

Aarti Drugs has reported total income of Rs. 599.81 crores during the period ended September 30, 2024 as compared to Rs. 556.45 crores during the period ended June 30, 2024. The company reported total income of Rs.642.22 crores during the period ended September 30, 2023.

For the Half Year ended FY25, Aarti Drugs has reported total income of Rs. 1,156.26 crores as compared to Rs. 1,303.93 crores during the 6 months period ended September 30, 2023.

Aarti Drugs has posted net profit of Rs. 68.25 crores for the 6 months period ended September 30, 2024 as against net profit of Rs.87.44 crores for the 6 months period ended September 30, 2023.

Upcoming E-conference

Other Related stories

Startup

Digitization